Home » Topics » BioWorld Science

BioWorld Science
RSS

LRFN1 gene as a possible cause of autism spectrum disorder

Oct. 21, 2021

Elevated plasma CXCL16 levels found in severe COVID-19 patients

Oct. 21, 2021

New spondyloarthritis therapeutic target identified

Oct. 21, 2021

FDG-PET signal is substantially affected by microglial glucose uptake in neurodegenerative diseases

Oct. 21, 2021

TCR2 Therapeutics enhances TRuC-T cells with IL-15 expression

Oct. 20, 2021

Retrotope reports data on RT-011 in animal models of retinal degeneration

Oct. 20, 2021

EDP-235 demonstrates potent antiviral activity against SARS-CoV-2 in cellular models

Oct. 20, 2021

Sanaria and Seattle Children's Research Institute partner on genetically attenuated malaria vaccines

Oct. 20, 2021

Missense mutation in the MMP14 gene causes autosomal dominant hypotrichosis

Oct. 20, 2021

Debiopharm awarded further funding to target N. gonorrhoeae

Oct. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...